Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
25-27 June, 2025
The Aesthetic ShowThe Aesthetic Show
Not Confirmed
Not Confirmed
26-29 June, 2025
Specialty & Agro Chemi...Specialty & Agro Chemical
Not Confirmed
Not Confirmed
29 June-01 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
25-27 June, 2025
The Aesthetic ShowThe Aesthetic Show
Industry Trade Show
Not Confirmed
26-29 June, 2025
Specialty & Agro Chemi...Specialty & Agro Chemical
Industry Trade Show
Not Confirmed
29 June-01 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025
02 Jun 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250602539645/en/Verastem-Oncology-Announces-Updated-Data-from-Partner-GenFleet-Therapeutics-Phase-1-Study-in-China-of-GFH375-VS-7375-an-Oral-KRAS-G12D-ONOFF-Inhibitor
28 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250528489524/en/Verastem-Oncology-to-Present-at-the-Jefferies-Global-Healthcare-Conference
22 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250522753974/en/Verastem-Oncology-Announces-Positive-Updated-Results-from-RAMP-205-Evaluating-Avutometinib-Plus-Defactinib-in-Combination-with-Standard-of-Care-Chemotherapy-in-Frontline-Metastatic-Pancreatic-Ductal-Adenocarcinoma
20 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250520003336/en/Tempus-Announces-a-Collaboration-with-Verastem-to-Develop-CDx-for-First-Ever-FDA-Approved-KRAS-Mutant-Recurrent-Low-Grade-Serous-Ovarian-Cancer-Combination-Treatment
13 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250513753037/en/Verastem-Oncology-Reports-First-Quarter-2025-Financial-Results-and-Highlights-Recent-Business-Updates
12 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/12/3079541/0/en/Onco360-Has-Been-Selected-as-a-National-Specialty-Pharmacy-Partner-for-AVMAPKI-FAKZYNJA-CO-PACK.html
ABOUT THIS PAGE